IC
CAH icon

Innealta Capital’s Cardinal Health CAH Stock Holding History

Innealta Capital’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7
Closed -$688 – 387
2024
Q2 		$688 Buy
+7
New +$713 ﹤0.01% 1403

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Innealta Capital's CAH Position: Q3 2024 in Review

Innealta Capital sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 7 shares — an estimated $688 sold.

Innealta Capital first reported a position in CAH in Q2 2024 and held it in 1 quarter. The position peaked at $688 in Q2 2024. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Innealta Capital reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 7 Cardinal Health shares in Q3 2024, an estimated $688.
  • Innealta Capital first reported a position in Cardinal Health in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Cardinal Health position peaked at $688 in Q2 2024.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.